CollPlant Biotechnologies Ltd. CLGN
4.12 USD +0.16 (+4.04%)
Nov 12, 2026, 10:54 AM EST
4.05 Day range 4.16
2.64 52-week range 22.50
- YTD
- -70.57%
- 1 year
- -78.20%
CLGN revenue history
Revenue is income from the company’s ordinary business activities.
2,371,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 2,371,000 | 1,856,000 | 360.39% |
| FY 2024 | 2024-12-31 | 515,000 | -10,444,000 | -95.30% |
| FY 2023 | 2023-12-31 | 10,959,000 | 10,660,000 | 3565.22% |
| FY 2022 | 2022-12-31 | 299,000 | -15,342,000 | -98.09% |
| FY 2021 | 2021-12-31 | 15,641,000 | 9,504,000 | 154.86% |
| FY 2020 | 2020-12-31 | 6,137,000 | 3,819,000 | 164.75% |
| FY 2019 | 2019-12-31 | 2,318,000 | -2,696,000 | -53.77% |
| FY 2018 | 2018-12-31 | 5,014,000 | 4,551,000 | 982.94% |
| FY 2017 | 2017-12-31 | 463,000 | 381,824 | 470.37% |
| FY 2016 | 2016-12-31 | 81,176 | 81,176 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-11T06:02:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.